🇺🇸 FDA
Pipeline program

Calquence 100 mg hard capsules

D8220C00008

Phase 3 small_molecule active

Quick answer

Calquence 100 mg hard capsules for Chronic lymphocytic leukemia is a Phase 3 program (small_molecule) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).

Program details

Company
AstraZeneca AB
Indication
Chronic lymphocytic leukemia
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials